Lung Cancer Surgery: Thoracoscopic Lobectomy And Wound Infection Rates Overview This meta-analysis rigorously examines the impact of thoracoscopic lobectomy on wound infection rates and complications among lung cancer patients. Through a comprehensive search across multiple databases, including PubMed, Embase, and Cochrane Library, among others, this study identified 21 relevant studies encompassing 2,118
Oncology
Pediatric Cancer: An App For Pain Management
Pediatric Cancer: An App For Pain Management Pain, a pervasive and troubling symptom in childhood cancer, manifests in a significant portion of patients, affecting between 40% to 78% of those undergoing treatment. This distressing experience can arise either directly from the illness itself or as an adverse effect of the treatments
Surgical Site Infection After Hysterectomy: A Meta-Analysis Of Risk Factors In Cancer Patients
Surgical Site Infection After Hysterectomy: A Meta-Analysis Of Risk Factors In Cancer Patients Endometrial cancer (EC) continues to pose a significant threat as the third leading cause of gynecological malignancy resulting in female mortality. In the year 2020 alone, there were 417,367 newly reported cases of endometrial cancer, contributing to the
Smoking And Mental Health After Lung Cancer Diagnosis
Smoking And Mental Health After Lung Cancer Diagnosis Overview This study investigated the emotional well-being, stigma experiences, and their connection to smoking history in individuals diagnosed with lung cancer. Analyzing data from 539 participants across various geographic locations from November 2019 to July 2022, the study utilized validated survey tools to assess
White Matter Brain Changes In Post-Chemotherapy Breast Cancer Patients
White Matter Brain Changes In Post-Chemotherapy Breast Cancer Patients Overview In this study, the objective was to evaluate white matter microstructural changes in older breast cancer survivors 5-15 years post-chemotherapy treatment. The participants included breast cancer survivors aged 65 or older who underwent chemotherapy (C+) and those who did not (C-), along
Radiosurgery Timing In Brain Cancer Patients
Radiosurgery Timing In Brain Cancer Patients Metastatic brain cancer, also known as brain metastases, occurs when cancer cells from a primary tumor elsewhere in the body spread to the brain. Metastatic brain cancer represents an advanced stage of cancer, indicating that cancer cells have already spread from their original site to
NSCLC First Line Therapy Chemotherapy Combinations
NSCLC First Line Therapy Chemotherapy Combinations Overview This retrospective study explores optimal first-line treatments for non-small cell lung cancer (NSCLC) patients with brain metastases (BMs) lacking driver gene alterations. The research compares the effectiveness of immunotherapy plus chemotherapy (ICI+Chemo) against bevacizumab plus chemotherapy (Beva+Chemo). The study, conducted between March 2017 and May
Colorectal Cancer: A Nomogram To Predict Metastases
Colorectal Cancer: A Nomogram To Predict Metastases Overview This study addresses the imperative task of identifying risk factors associated with distant metastasis in early-onset colorectal cancer (EOCRC), aiming to enhance understanding of its etiology and facilitate preventive treatments. The research, utilizing data from EOCRC patients in the SEER database (2010-2015), seeks to
Tongue Tumor Staging Using Artificial Intelligence
Tongue Tumor Staging Using Artificial Intelligence Overview This study addresses the critical issue of misdiagnosis in determining the stage of tongue tumor development, which can lead to varied treatment approaches and hinder patients from receiving appropriate care. The research aims to establish an automatic recognition system for different stages of tongue tumors,
Busulfan Exposure And Malignancy Risk
Busulfan Exposure And Malignancy Risk Overview The occurrence of secondary malignancies linked to busulfan exposure is deemed low but remains insufficiently characterized. Given the rising use of this alkylating agent in pre-gene therapy conditioning for nonmalignant hematologic disorders, a more precise understanding of busulfan's potential contribution to subsequent malignancy risk is essential.
